Hip Disease Research Center, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), 82 Qiming South Road, Luoyang, 471000, Henan, China.
Quality Management Department, Luoyang Orthopedic-Traumatological Hospital of Henan Province (Henan Provincial Orthopedic Hospital), Luoyang, 471000, China.
J Orthop Surg Res. 2021 Aug 12;16(1):492. doi: 10.1186/s13018-021-02632-x.
This study aimed to evaluate the clinical efficacy of femoral head and neck fenestration combined with autologous bone mixed with β-tricalcium phosphate porous bioceramic bone (light bulb procedure) through Orthopdische Chirurgie München approach (OCM approach) for pre-collapse non-traumatic osteonecrosis of the femoral head(ONFH).
The clinical data of 47 patients (47 hips) with ONFH were retrospectively reviewed. The Harris hip score (HHS) was used to evaluate the clinical outcomes. Imaging was assessed by X-ray. Clinical failure was defined as postoperative total hip arthroplasty (THA) or the HHS was poor (< 70). The Kaplan-Meier survival curve was used to conduct a univariate analysis of risk factors. The analysis factors included gender, age, International Association Research Circulation Osseous (ARCO) stage, etiology, body mass index (BMI), 25-hydroxyvitamin D (25(OH)D), and type I collagen carboxy-terminal peptide (CTX). The COX multivariate risk model was used to analyze the risk factors.
All the 47 hips were followed up for 24-58 months, with an average of 45 months. The Harris score (76.29 ± 10.38) at the last follow-up was significantly higher than the preoperative HHS (64.45 ± 2.93) (P < 0.05). The postoperative HHS was excellent with a success rate of 36.17%. Postoperative imaging evaluation showed that 9 hips improved, 28 hips stabilized, and 10 hips progressed. Moreover, 17 out of 47 hips were defined as a postoperative clinical failure and the success rate was 63.83%. 25(OH)D and preoperative ARCO stage were risk factors for postoperative clinical failure (P < 0.05). The COX multivariate risk model analysis showed that IIIA stage was an independent risk factor for postoperative clinical failure (P < 0.05).
The head and neck fenestration and bone grafting via the OCM approach in the treatment of non-traumatic ONFH in the pre-collapse stage can achieve good clinical outcomes. 25(OH)D deficient patients and ARCO IIIA patients had a higher failure rate of bone graft using this approach.
本研究旨在评估经 Orthopdische Chirurgie München 入路(OCM 入路)行股骨头颈开窗并联合自体骨混合β-磷酸三钙多孔生物陶瓷骨(灯泡样手术)治疗非创伤性股骨头坏死(ONFH)塌陷前期的临床疗效。
回顾性分析 47 例(47 髋)ONFH 患者的临床资料,采用 Harris 髋关节评分(HHS)评估临床疗效,X 线评估影像学表现。术后全髋关节置换术(THA)或 HHS 较差(<70 分)定义为临床失败。采用 Kaplan-Meier 生存曲线进行单因素分析,分析因素包括性别、年龄、国际骨循环研究会(ARCO)分期、病因、体重指数(BMI)、25-羟维生素 D(25(OH)D)、I 型胶原羧基端肽(CTX)。采用 COX 多因素风险模型分析危险因素。
47 髋均获随访,随访时间 24~58 个月,平均 45 个月。末次随访时 Harris 评分(76.29±10.38)较术前 HHS(64.45±2.93)显著提高(P<0.05)。术后 HHS 优良率为 36.17%。术后影像学评估示 9 髋改善,28 髋稳定,10 髋进展。47 髋中 17 髋术后临床失败,成功率为 63.83%。25(OH)D 和术前 ARCO 分期是术后临床失败的危险因素(P<0.05)。COX 多因素风险模型分析显示 ARCO IIIA 期是术后临床失败的独立危险因素(P<0.05)。
OCM 入路行股骨头颈开窗并联合自体骨混合β-磷酸三钙多孔生物陶瓷骨治疗非创伤性塌陷前期 ONFH 可获得良好的临床疗效,25(OH)D 缺乏和 ARCO IIIA 期患者采用该术式植骨失败率更高。